143 related articles for article (PubMed ID: 37916832)
1. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Development and external validation of a breast cancer absolute risk prediction model in Chinese population.
Han Y; Lv J; Yu C; Guo Y; Bian Z; Hu Y; Yang L; Chen Y; Du H; Zhao F; Wen W; Shu XO; Xiang Y; Gao YT; Zheng W; Guo H; Liang P; Chen J; Chen Z; Huo D; Li L;
Breast Cancer Res; 2021 May; 23(1):62. PubMed ID: 34051827
[TBL] [Abstract][Full Text] [Related]
4. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
5. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
Louro J; Román M; Posso M; Vázquez I; Saladié F; Rodriguez-Arana A; Quintana MJ; Domingo L; Baré M; Marcos-Gragera R; Vernet-Tomas M; Sala M; Castells X;
PLoS One; 2021; 16(3):e0248930. PubMed ID: 33755692
[TBL] [Abstract][Full Text] [Related]
6. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
7. Development of a Prognostic App (iCanPredict) to Predict Survival for Chinese Women With Breast Cancer: Retrospective Study.
Ma Z; Huang S; Wu X; Huang Y; Chan SW; Lin Y; Zheng X; Zhu J
J Med Internet Res; 2022 Mar; 24(3):e35768. PubMed ID: 35262503
[TBL] [Abstract][Full Text] [Related]
8. Machine-learning Models Predict 30-Day Mortality, Cardiovascular Complications, and Respiratory Complications After Aseptic Revision Total Joint Arthroplasty.
Abraham VM; Booth G; Geiger P; Balazs GC; Goldman A
Clin Orthop Relat Res; 2022 Nov; 480(11):2137-2145. PubMed ID: 35767804
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prediction model for early screening of people at high risk for colorectal cancer.
Xu LL; Lin Y; Han LY; Wang Y; Li JJ; Dai XY
World J Gastroenterol; 2024 Feb; 30(5):450-461. PubMed ID: 38414586
[TBL] [Abstract][Full Text] [Related]
10. A prognostic nomogram and risk classification system of elderly patients with extraosseous plasmacytoma: a SEER database analysis.
Chen Y; Tang M; Fu Y; Zhuang X; Wei R; Chen Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17921-17931. PubMed ID: 37955685
[TBL] [Abstract][Full Text] [Related]
11. Predicting 1-, 3-, 5-, and 8-year all-cause mortality in a community-dwelling older adult cohort: relevance for predictive, preventive, and personalized medicine.
Chen Y; Deng X; Lin D; Yang P; Wu S; Wang X; Zhou H; Chen X; Wang X; Wu W; Ke K; Huang W; Tan X
EPMA J; 2023 Dec; 14(4):713-726. PubMed ID: 38094581
[TBL] [Abstract][Full Text] [Related]
12. Electronic Health Record-Based Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation.
Han Y; Zhu X; Hu Y; Yu C; Guo Y; Hang D; Pang Y; Pei P; Ma H; Sun D; Yang L; Chen Y; Du H; Yu M; Chen J; Chen Z; Huo D; Jin G; Lv J; Hu Z; Shen H; Li L
JMIR Public Health Surveill; 2023 Mar; 9():e43725. PubMed ID: 36781293
[TBL] [Abstract][Full Text] [Related]
13. Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian Women.
Yang Y; Tao R; Shu X; Cai Q; Wen W; Gu K; Gao YT; Zheng Y; Kweon SS; Shin MH; Choi JY; Lee ES; Kong SY; Park B; Park MH; Jia G; Li B; Kang D; Shu XO; Long J; Zheng W
JAMA Netw Open; 2022 Mar; 5(3):e2149030. PubMed ID: 35311964
[TBL] [Abstract][Full Text] [Related]
14. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
[TBL] [Abstract][Full Text] [Related]
15. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
[TBL] [Abstract][Full Text] [Related]
16. A deep-learning-based clinical risk stratification for overall survival in adolescent and young adult women with breast cancer.
Luo J; Diao B; Wang J; Yin K; Guo S; Hong C; Guo Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10423-10433. PubMed ID: 37277578
[TBL] [Abstract][Full Text] [Related]
17. A risk prediction model for selecting high-risk population for computed tomography lung cancer screening in China.
Guo LW; Lyu ZY; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Cao XQ; Liu SZ; Sun XB; Zhang JG; Zhang SK
Lung Cancer; 2022 Jan; 163():27-34. PubMed ID: 34894456
[TBL] [Abstract][Full Text] [Related]
18. Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China.
Zheng Y; Dong X; Li J; Qin C; Xu Y; Wang F; Cao W; Xia C; Yu Y; Zhao L; Wu Z; Luo Z; Chen W; Li N; He J
JAMA Netw Open; 2022 Nov; 5(11):e2241441. PubMed ID: 36355372
[TBL] [Abstract][Full Text] [Related]
19. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study.
Clift AK; Dodwell D; Lord S; Petrou S; Brady M; Collins GS; Hippisley-Cox J
BMJ; 2023 May; 381():e073800. PubMed ID: 37164379
[TBL] [Abstract][Full Text] [Related]
20. [Development and validation of risk prediction model for new-onset cardiovascular diseases among breast cancer patients: Based on regional medical data of Inner Mongolia].
Zhang YJ; Qiao LY; Qi M; Yan Y; Kang WW; Liu GZ; Wang MY; Xi YF; Wang SF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):471-479. PubMed ID: 37291923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
